GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $21,438,000 | +94.7% | 98,842 | +3.6% | 0.01% | +100.0% |
| Q4 2020 | $11,009,000 | +12.6% | 95,387 | -5.0% | 0.00% | +50.0% |
| Q3 2020 | $9,778,000 | -43.5% | 100,437 | -28.8% | 0.00% | -60.0% |
| Q2 2020 | $17,307,000 | +42.4% | 141,024 | +1.6% | 0.01% | +25.0% |
| Q1 2020 | $12,154,000 | -44.5% | 138,784 | -33.8% | 0.00% | -33.3% |
| Q4 2019 | $21,916,000 | +19.1% | 209,598 | +31.1% | 0.01% | +20.0% |
| Q3 2019 | $18,394,000 | -3.7% | 159,906 | +44.3% | 0.01% | 0.0% |
| Q2 2019 | $19,099,000 | -18.4% | 110,789 | -20.2% | 0.01% | -28.6% |
| Q1 2019 | $23,407,000 | +37.9% | 138,857 | -20.3% | 0.01% | +40.0% |
| Q4 2018 | $16,977,000 | -15.1% | 174,314 | +50.6% | 0.01% | 0.0% |
| Q3 2018 | $19,990,000 | +453.6% | 115,719 | +347.2% | 0.01% | +400.0% |
| Q2 2018 | $3,611,000 | -70.9% | 25,879 | -76.5% | 0.00% | -66.7% |
| Q1 2018 | $12,406,000 | -44.2% | 110,106 | -34.7% | 0.00% | -40.0% |
| Q4 2017 | $22,245,000 | +158.0% | 168,513 | +98.4% | 0.01% | +150.0% |
| Q3 2017 | $8,621,000 | +77.1% | 84,942 | +74.9% | 0.00% | +100.0% |
| Q2 2017 | $4,868,000 | +22.9% | 48,559 | +48.3% | 0.00% | 0.0% |
| Q1 2017 | $3,960,000 | -94.7% | 32,743 | -95.1% | 0.00% | -95.5% |
| Q4 2016 | $75,306,000 | +549.3% | 673,882 | +671.2% | 0.02% | +450.0% |
| Q3 2016 | $11,598,000 | +57.3% | 87,384 | +8.5% | 0.00% | +100.0% |
| Q2 2016 | $7,372,000 | -52.7% | 80,515 | -62.8% | 0.00% | -60.0% |
| Q1 2016 | $15,599,000 | +44.4% | 216,205 | +39.0% | 0.01% | +25.0% |
| Q4 2015 | $10,800,000 | +4.4% | 155,529 | +37.4% | 0.00% | +33.3% |
| Q3 2015 | $10,345,000 | +2499.2% | 113,218 | +2494.4% | 0.00% | – |
| Q1 2015 | $398,000 | -63.8% | 4,364 | -73.2% | 0.00% | – |
| Q4 2014 | $1,100,000 | +368.1% | 16,255 | +458.2% | 0.00% | – |
| Q3 2014 | $235,000 | -68.8% | 2,912 | -58.6% | 0.00% | – |
| Q2 2014 | $754,000 | -42.9% | 7,026 | -68.4% | 0.00% | – |
| Q1 2014 | $1,320,000 | – | 22,219 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |